Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China

BackgroundLipid-lowering therapy (LLT) is one of the key strategies for reducing the atherosclerotic cardiovascular disease (ASCVD) burden. However, little is known about the percentage of people in need of different LLT regimens to achieve optimal targets of low-density lipoprotein cholesterol (LDL...

Full description

Bibliographic Details
Main Authors:	Lei Bi, Jiayi Yi, Chaoqun Wu, Shuang Hu, Xingyi Zhang, Jiapeng Lu, Jiamin Liu, Haibo Zhang, Yang Yang, Jianlan Cui, Wei Xu, Lijuan Song, Yuanlin Guo, Xi Li, Xin Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	ASCVD risk LDL-C goals lipid-lowering therapy simulation statins ezetimibe
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.839571/full

Similar Items

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
by: Chen CC, et al.
Published: (2018-12-01)

Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
by: Na-Qiong Wu, et al.
Published: (2018-11-01)

Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline
by: Chibuike J. Alanaeme, et al.
Published: (2022-09-01)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature
by: Min Yu, et al.
Published: (2020-01-01)

Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease
by: Danh Q. Nguyen, et al.
Published: (2024-06-01)

Evolocumab safety and efficacy in hypercholesterolemia patients with or without diabetes: a retrospective real-world analysis
by: Sultan Ibrahim Alraddadi, et al.
Published: (2025-01-01)

Safety of significant, long-term lipid lowering therapy. Focus on inclisiran, with Braunwald's vision
by: László Márk
Published: (2024-04-01)

Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database
by: Dimitrios Terentes-Printzios, et al.
Published: (2024-06-01)

Audit on lipid screening, management and target achievement in prevention of cardiovascular disease in patients attending a medical clinic in National Hospital Kandy: Are we on par with the guidelines?
by: F. N. Nasim, et al.
Published: (2023-02-01)

Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial
by: Keun-Sik Hong, et al.
Published: (2023-05-01)

The clinical effectiveness and safety of low/moderate-intensity statins & ezetimibe combination therapy vs. high-intensity statin monotherapy: a systematic review and meta-analysis
by: Pishoy Sydhom, et al.
Published: (2024-11-01)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
by: Natalie C. Ward, et al.
Published: (2022-11-01)

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
by: Hines DM, et al.
Published: (2018-12-01)

Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry
by: Izza Shahid, et al.
Published: (2024-09-01)

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
by: Omar Mhaimeed, et al.
Published: (2024-06-01)

Effect of plant sterols compared with ezetimibe on oxidative stress in patients treated with statins
by: Adriana Bertolami, et al.
Published: (2014-09-01)

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience
by: Chad Gier, et al.
Published: (2024-01-01)

Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting
by: Marat V. Ezhov, et al.
Published: (2023-11-01)

IMPROVE-IT
by: Eldrin F. Lewis, MD, MPH, et al.
Published: (2020-09-01)

Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation
by: Minyoung Oh, et al.
Published: (2019-08-01)

Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01)

Role of Ezetimibe in Combination with Statins(Simvastatin and Atorvastatin) in Controlling Dyslipidemia
by: Falah H.Al-Malki, et al.
Published: (2017-03-01)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
by: Yinchu Cheng, et al.
Published: (2022-10-01)

Editorial: New and emerging lipid-lowering therapies for reducing cardiovascular risk: beyond statins
by: Fei Luo, et al.
Published: (2024-01-01)

Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?
by: Lina Ya'Qoub, et al.
Published: (2023-09-01)

Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review
by: Nikolaos Velidakis, et al.
Published: (2024-04-01)

Efficacy of Ezetimibe/Simvastatin (10/10 mg) Versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials
by: Gaoming YANG, et al.
Published: (2019-07-01)

Secondary Cardiovascular Disease Prevention Deficit Persists over the Years: A Multicenter Cross-Sectional Study Involving 1003 Consecutive Patients from Greece
by: Rodis D. Paparodis, et al.
Published: (2024-03-01)

A 10-Year Risk Assessment and Primary Prevention Study of Atherosclerotic Cardiovascular Disease Among Adult Patients in Saudi Arabia: A Cross-Sectional Study
by: Abdulhameed Alkhalaf, et al.
Published: (2025-01-01)

Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe
by: N. V. Fedorova, et al.
Published: (2021-06-01)

Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?
by: Panagiotis Anagnostis, et al.
Published: (2023-01-01)

Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults
by: Aaron J. Walker, et al.
Published: (2024-06-01)

Adherence to the 2018 AHA cholesterol management guideline in hyperlipidemia treatment among adults in an outpatient setting
by: Bahere Behdani, et al.
Published: (2024-07-01)

Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system
by: Neha M. Mantri, et al.
Published: (2022-12-01)

Self- vs provider-referral differences for coronary artery calcium testing
by: Rebekah Lantz, et al.
Published: (2022-01-01)

LDL Cholesterol, Statins And PCSK 9 Inhibitors
by: Sanjiv Gupta
Published: (2015-09-01)

Prevalence of Tendon Rupture and Tendinopathies Among Patients with Atherosclerotic Cardiovascular Disease Derived From United States Administrative Claims Data
by: Kristin K. Gillard, et al.
Published: (2024-07-01)

Lipid Control Post Coronary Artery Bypass Graft: One Year Follow-Up of a Middle-Eastern Cohort
by: Bassam Atallah, et al.
Published: (2020-02-01)

The efficacy and safety of statin in combination with ezetimibe compared with double-dose statin in patients with high cardiovascular risk: A meta-analysis
by: Yunyun Zhu, et al.
Published: (2020-05-01)